Aberrant glycosylation of key synaptic proteins like amyloid precursor protein (APP) and tau can disrupt their normal physiological functions, thereby contributing to the progressive synaptic loss and dysfunction characteristic of AD [223]. The gene discussed is MAPT; the disease is Alzheimer disease.